AMG 193 + Other Therapies in Advanced GI & PDAC with homozygous MTAP-deletion (20230223)

Who Can Participate in the Study?

Age Group
Adults

Study Details

Full Title
A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 193 in Combination With other Therapies in Subjects With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous MTAP-deletion Master Protocol (20230223)
Principal Investigator
Headshot of Niharika Bansal Mettu
Associate Professor of Medicine
Protocol Number
IRB: PRO00116091
NCT: NCT06360354
Phase
Phase I
ClinicalTrials.gov
Enrollment Status
OPEN TO ACCRUAL